APA (7th ed.) Citation

Butler, M., Reichstein, D., Krema, H., Mckean, M., Joshua, A., Lim, L., . . . Shields, C. (2025). 1602O Enucleation prevention and vision preservation in primary uveal melanoma (UM): Preliminary results from a phase II study of neoadjuvant darovasertib. Annals of Oncology, 36, S947. https://doi.org/10.1016/j.annonc.2025.08.2230

Chicago Style (17th ed.) Citation

Butler, M.O, et al. "1602O Enucleation Prevention and Vision Preservation in Primary Uveal Melanoma (UM): Preliminary Results from a Phase II Study of Neoadjuvant Darovasertib." Annals of Oncology 36 (2025): S947. https://doi.org/10.1016/j.annonc.2025.08.2230.

MLA (9th ed.) Citation

Butler, M.O, et al. "1602O Enucleation Prevention and Vision Preservation in Primary Uveal Melanoma (UM): Preliminary Results from a Phase II Study of Neoadjuvant Darovasertib." Annals of Oncology, vol. 36, 2025, p. S947, https://doi.org/10.1016/j.annonc.2025.08.2230.